Subcutaneous exendin treats post-bariatric hypoglycemia
(HealthDay)—Subcutaneous exendin (SC Ex-9) appears to be safe and effective in treating post-bariatric hypoglycemia (PBH), according to a study published online Aug. 4 in Diabetes, Obesity and Metabolism.
Aug 11, 2017
0
0